118 related articles for article (PubMed ID: 21099417)
1. A multicenter, double-blind, parallel group, placebo-controlled clinical study to examine the safety and efficacy of T-Clair SPHP700-3 in the management of mild to moderate dry eye in adults.
Villani E; Laganovska G; Viola F; Pirondini C; Baumane K; Radecka L; Ratiglia R
Cornea; 2011 Mar; 30(3):265-8. PubMed ID: 21099417
[TBL] [Abstract][Full Text] [Related]
2. Demonstration of efficacy in the treatment of dry eye disease with 0.18% sodium hyaluronate ophthalmic solution (vismed, rejena).
Vogel R; Crockett RS; Oden N; Laliberte TW; Molina L;
Am J Ophthalmol; 2010 Apr; 149(4):594-601. PubMed ID: 20346777
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of diquafosol ophthalmic solution in patients with dry eye syndrome: a Japanese phase 2 clinical trial.
Matsumoto Y; Ohashi Y; Watanabe H; Tsubota K;
Ophthalmology; 2012 Oct; 119(10):1954-60. PubMed ID: 22739038
[TBL] [Abstract][Full Text] [Related]
4. Ocular tolerability and efficacy of a cationic emulsion in patients with mild to moderate dry eye disease - a randomised comparative study.
Amrane M; Creuzot-Garcher C; Robert PY; Ismail D; Garrigue JS; Pisella PJ; Baudouin C
J Fr Ophtalmol; 2014 Oct; 37(8):589-98. PubMed ID: 25127703
[TBL] [Abstract][Full Text] [Related]
5. Safety and efficacy of cyclosporine 0.05% drops versus unpreserved artificial tears in dry-eye patients having laser in situ keratomileusis.
Salib GM; McDonald MB; Smolek M
J Cataract Refract Surg; 2006 May; 32(5):772-8. PubMed ID: 16765793
[TBL] [Abstract][Full Text] [Related]
6. Demonstration of efficacy in the treatment of dry eye disease with 0.18% sodium hyaluronate ophthalmic solution (vismed, rejena).
Tawfik HA
Am J Ophthalmol; 2010 Nov; 150(5):757; author reply 757. PubMed ID: 21036218
[No Abstract] [Full Text] [Related]
7. Phase III safety evaluation of cyclosporine 0.1% ophthalmic emulsion administered twice daily to dry eye disease patients for up to 3 years.
Barber LD; Pflugfelder SC; Tauber J; Foulks GN
Ophthalmology; 2005 Oct; 112(10):1790-4. PubMed ID: 16102833
[TBL] [Abstract][Full Text] [Related]
8. Rebamipide (OPC-12759) in the treatment of dry eye: a randomized, double-masked, multicenter, placebo-controlled phase II study.
Kinoshita S; Awamura S; Oshiden K; Nakamichi N; Suzuki H; Yokoi N;
Ophthalmology; 2012 Dec; 119(12):2471-8. PubMed ID: 23009892
[TBL] [Abstract][Full Text] [Related]
9. Trehalose versus hyaluronan or cellulose in eyedrops for the treatment of dry eye.
Matsuo T
Jpn J Ophthalmol; 2004; 48(4):321-7. PubMed ID: 15295655
[TBL] [Abstract][Full Text] [Related]
10. Carbomer and sodium hyaluronate eyedrops for moderate dry eye treatment.
Johnson ME; Murphy PJ; Boulton M
Optom Vis Sci; 2008 Aug; 85(8):750-7. PubMed ID: 18677239
[TBL] [Abstract][Full Text] [Related]
11. Choice of artificial tear formulation for patients with dry eye: where do we start?
Tong L; Petznick A; Lee S; Tan J
Cornea; 2012 Nov; 31 Suppl 1():S32-6. PubMed ID: 23038032
[TBL] [Abstract][Full Text] [Related]
12. Safety of Lifitegrast Ophthalmic Solution 5.0% in Patients With Dry Eye Disease: A 1-Year, Multicenter, Randomized, Placebo-Controlled Study.
Donnenfeld ED; Karpecki PM; Majmudar PA; Nichols KK; Raychaudhuri A; Roy M; Semba CP
Cornea; 2016 Jun; 35(6):741-8. PubMed ID: 27055211
[TBL] [Abstract][Full Text] [Related]
13. Relative costs of various preserved artificial tear solutions for the treatment of dry eye conditions.
Enzenauer RW; Kao A; Williams T; Lambert RW
Eye Contact Lens; 2003 Oct; 29(4):238-40. PubMed ID: 14555900
[TBL] [Abstract][Full Text] [Related]
14. A comparative clinical trial of the efficacy of two different aqueous solutions of cyclosporine for the treatment of moderate-to-severe dry eye syndrome.
Baiza-Durán L; Medrano-Palafox J; Hernández-Quintela E; Lozano-Alcazar J; Alaníz-de la O JF
Br J Ophthalmol; 2010 Oct; 94(10):1312-5. PubMed ID: 20679084
[TBL] [Abstract][Full Text] [Related]
15. Issues in the use of preservative-free topicals.
Perry HD; Donnenfeld ED
Manag Care; 2003 Dec; 12(12 Suppl):39-41. PubMed ID: 14723113
[TBL] [Abstract][Full Text] [Related]
16. Effect of povidone 2% preservative-free eyedrops on contact lens wearers with computer visual syndrome: pilot study.
Guillon M; Maissa C; Pouliquen P; Delval L
Eye Contact Lens; 2004 Jan; 30(1):34-9. PubMed ID: 14722467
[TBL] [Abstract][Full Text] [Related]
17. Effect of an oil-in-water emulsion on the tear physiology of patients with mild to moderate dry eye.
Khanal S; Tomlinson A; Pearce EI; Simmons PA
Cornea; 2007 Feb; 26(2):175-81. PubMed ID: 17251808
[TBL] [Abstract][Full Text] [Related]
18. [Effectiveness, tolerance and acceptance of polyvidon preparations].
Höh H; Fink R; Dehnicke C; Klöcker N
Klin Monbl Augenheilkd; 1999 Oct; 215(4):A8-14. PubMed ID: 10572880
[No Abstract] [Full Text] [Related]
19. [A new therapy concept for the treatment of dry eye--the usefulness of phospholipid liposomes].
Lee S; Dausch S; Maierhofer G; Dausch D
Klin Monbl Augenheilkd; 2004 Oct; 221(10):825-36. PubMed ID: 15499517
[TBL] [Abstract][Full Text] [Related]
20. An evaluation of the efficacy of fluorescein, rose bengal, lissamine green, and a new dye mixture for ocular surface staining.
Korb DR; Herman JP; Finnemore VM; Exford JM; Blackie CA
Eye Contact Lens; 2008 Jan; 34(1):61-4. PubMed ID: 18180687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
